Martin Lord
Uppsala, C 75237, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange.
Journal: International journal of biological macromolecules
Published: August 27, 2025
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement.
Journal: Molecular therapy. Oncology
Published: October 02, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.
Journal: Nature communications
Published: July 04, 2023
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies.
Journal: Chembiochem : a European journal of chemical biology
Published: February 07, 2023
Salivary biglycan-neo-epitope-BGN262: A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.
Journal: Osteoarthritis and cartilage open
Published: October 25, 2022
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Journal: Journal of internal medicine
Published: August 30, 2021
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Journal: Immunity, inflammation and disease
Published: July 15, 2021
Last Updated: 09/26/2026